Use fundamental data analysis to check out all available financial ratios of Medigus Ltd to find out if markets are presently mispricing the entity. We found twenty-seven available fundamentals for Medigus Ltd which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Medigus Ltd fundamentals including its Shares Outstanding, Price to Book, Revenue, as well as the relationship between Price to Earning and Price to Sales . Use Medigus Ltd to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Medigus Ltd to be traded at S67.65 in 30 days
Medigus Ltd Company Summary
Medigus Ltd competes with Mazor Robotics, Elbit Medical, Medtechnica Ltd, and BioView Ltd. Medigus Ltd., a medical device company, develops, manufactures, and markets surgical endostaplers and direct vision systems for minimally invasive medical procedures or other commercial use in the United States, Europe, Asia, and internationally. Medigus Ltd. was founded in 1999 and is based in Omer, Israel. Medigus Ltd operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 27 people.